ArticleEndoscopy international open2026
Endoscopic ultrasound-guided transgastric drainage of pancreaticopleural fistulas.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and study aims: Pancreaticopleural fistula (PPF) is a rare complication of chronic pancreatitis with prevalence of 0.4%. Drainage under endoscopic ultrasound (EUS) guidance may offer an alternative with unassessed efficacy and safety. This case series aimed to initially assess efficacy and safety of EUS-guided transgastric drainage of PPF. Patients and methods: This was a retrospective case series that analyzed outcomes of EUS-guided drainage in four patients with PPF. The study was carried out at the Department of General, Gastroenterological, and Oncological Surgery, Collegium Medicum, Nicolaus Copernicus University in Torun (Poland), between 2021-2023. Results: PPF was identified in four patients with chronic pancreatitis. Fistula tracts were arising from the body (2/4;50%), tail (1/4; 25%), and neck (1/4; 25%). Mean fistula diameter and length were 26.25 mm (15-50 mm) and 107.5 (80-150 mm), respectively. Due to inefficiency of conservative treatment and transpapillary drainage in endoscopic retrograde cholangiopancreatography (ERCP), EUS-guided transgastric/transmural drainage of the PPF was performed using metal or plastic stents. Technical and clinical success was achieved in all patients with no adverse events (AEs). Mean hospital stay was 7.75 days (5-12 days), and symptoms resolved in all patients. All stents were removed. There was no recurrence during mean follow-up of 603.5 days (93-1236 days). Conclusions: EUS-guided transgastric drainage appears to be a promising alternative for refractory PPF, resulting in technical and clinical success with minimal AEs. Long-term follow-up underscores sustained symptom resolution and absence of recurrence, highlighting its potential in managing this challenging complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.